Reporting of determinants of health inequities and participant characteristics in randomized controlled trials of juvenile idiopathic arthritis in Canada: a scoping review

Table 1 Characteristics of included studies and reporting of PROGRESS-Plus factors

Study ID	Type of intervention	Intervention	N	Age	%Female	R	G	E	S	P1	P2
Dupuis 1995 (13)	Pharmacological	Usual Methotrexate dose was given either orally (fasting and non-fasting) or via IV injection in the morning for 3 consecutive weeks	14	8.39	71.4		X			X
Singh-Grewal 2007 (17)	Non-pharmacological	High intensity aerobics exercise vs. quigong for 12 weeks, 3 times per week	80	11.6	79.9		X			X
Stinson 2016 (15)	Non-pharmacological	Video calls with peer mentors (adolescents with managed Juvenile Idiopathic Arthritis )	30	14.1	94.0		X	X		X
Stinson 2020 (16)	Non-pharmacological	A website containing specific coping and stress management methods compared to a general Juvenile Idiopathic Arthritis education website	219	14.4	70.3		X		X	X	X
Lalloo 2021 (14)	Non-pharmacological	iCanCope app and app with only symptom tracking	60	15.0	78.3	X	X			X

X denotes factor reported in the study and blank cells denote factor not reported;
PROGRESS-Plus Factors: P (Place of residence), R (Race/ethnicity/culture/language), O (Occupation), G (Gender/sex), R (Religion), E (Education), S (Socioeconomic status), S (Social Capital), P1 (Personal characteristics associated with discrimination), P2 (Features of relationships), P3 (Time-dependent relationships).

ISSN: 1546-0096